393

Compound name
Radotinib
Alt Name
Supect
Compound Image
Radotinib.png
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5
Brutto
C27H21F3N8O
InChI
InChI=1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37)
InChI Key
DUPWHXBITIZIKZ-UHFFFAOYSA-N
Approval Jurisdiction
2012 FDA
Approved for clinical use
Chronic Myelogenous Leukemia
CAS
926037-48-1
PubChem CID
16063245
Action
Bcr-Ab1, PDGFR
Approved Drug List
1
Commercial Vendor
Daewoong